Option Care Health insider purchase: 1,000 shares acquired by director

Rhea-AI Filing Summary

Insider purchase disclosed: Option Care Health director David W. Golding acquired 1,000 shares of the company's common stock on 08/21/2025 at a price of $27.625 per share. After the purchase, Mr. Golding beneficially owned 116,525 shares, held directly. The Form 4 was signed on behalf of Mr. Golding by attorney-in-fact Michael Shapiro.

Positive

• Director purchase recorded: 1,000 shares acquired, which increases the reporting person's direct ownership to 116,525 shares.
• Transparent reporting: Transaction details (date, price, amount) and attorney-in-fact signature are provided on the Form 4.

Negative

• None.

Insights

Financial Analyst

TL;DR: A director executed a small open-market purchase of 1,000 shares, modestly increasing direct ownership.

The filing reports a single non-derivative acquisition: 1,000 shares at $27.625 each on 08/21/2025, raising the reporting person's direct holdings to 116,525 shares. For most investors this is a routine insider purchase and does not indicate a material shift in control or capital structure. The transaction size appears modest relative to typical company-wide float, and no derivatives or disposition events are reported.

Corporate Governance Expert

TL;DR: Director purchase documented and properly reported via Form 4 with attorney-in-fact signature.

The Form 4 identifies David W. Golding as a director and discloses a direct purchase of common stock, with the Form signed by an attorney-in-fact. The filing includes required details: transaction date, price, amount acquired, and post-transaction beneficial ownership. There are no amendments, joint filings, or indications of Rule 10b5-1 plans noted in the document.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GOLDING DAVID W

(Last) (First) (Middle)

C/O OPTION CARE HEALTH, INC.

3000 LAKESIDE DRIVE, SUITE 300N

(Street)

BANNOCKBURN IL 60015

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Option Care Health, Inc. [ OPCH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/21/2025		P		1,000	A	$27.625	116,525	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Michael Shapiro, attorney-in-fact for Mr. Golding	08/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did OPCH director David W. Golding report on 08/21/2025?

He reported a purchase of 1,000 shares of Option Care Health common stock at $27.625 per share on 08/21/2025.

How many shares does David W. Golding beneficially own after the reported transaction?

After the transaction he beneficially owned 116,525 shares, held directly.

Was the Form 4 filed jointly or by a single reporting person for OPCH?

The Form 4 was filed by one reporting person (the box indicating a single filer is checked).

Who signed the Form 4 for David W. Golding?

The Form 4 was signed by Michael Shapiro, attorney-in-fact for Mr. Golding on 08/21/2025.

Did the filing report any derivative securities or dispositions for Mr. Golding?

No. The filing lists only a non-derivative acquisition of common stock and does not report derivative securities or dispositions.